Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 62,741 |
|
|||||
| News | - | ||||||
| Day High | 22.12 | Low High |
|||||
| Day Low | 21.02 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| NewAmsterdam Pharma Company NV | NAMS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.41 | 1.91% | 21.85 | 23:00:05 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 21.13 | 21.02 | 22.12 | 21.99 | 21.44 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 886 | 62,741 | US$ 21.63 | US$ 1,356,945 | - | 5.6326 - 26.35 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:25:53 | formt | 500 | US$ 21.85 | USD |
NewAmsterdam Pharma Company NV Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.96B | 89.27M | - | 14.09M | -176.94M | -1.98 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NewAmsterdam Pharma Comp... News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NAMS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 19.21 | 22.28 | 19.21 | 20.99 | 120,490 | 2.64 | 13.74% |
| 1 Month | 23.80 | 24.79 | 18.22 | 20.06 | 232,201 | -1.95 | -8.19% |
| 3 Months | 20.50 | 24.99 | 18.22 | 21.10 | 227,076 | 1.35 | 6.59% |
| 6 Months | 5.95 | 26.35 | 5.6326 | 18.02 | 194,263 | 15.90 | 267.23% |
| 1 Year | 14.80 | 26.35 | 5.6326 | 15.56 | 144,084 | 7.05 | 47.64% |
| 3 Years | 11.00 | 32.88 | 5.6326 | 15.18 | 115,139 | 10.85 | 98.64% |
| 5 Years | 11.00 | 32.88 | 5.6326 | 15.18 | 115,139 | 10.85 | 98.64% |
NewAmsterdam Pharma Comp... Description
| NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib, a next generation, oral, and low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in four ongoing Phase 3 and Phase 2b clinical trials as both a monotherapy and a combination therapy with ezetimibe for lowering LDL-C and preventing major adverse cardiovascular events (MACE). NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands. |
